Larvol Delta - Caribou-Biosciences-Reports-Positive-Additional-Data-from-CB010-Allogeneic-CART-Cell-Therapy-Phase-1-ANTLER-Trial-at-the-European-Hematology-Association-EHA-2022-Hybrid-Congress

CB-010 - Caribou Biosci

https://www.globenewswire.com/news-release/2022/06/10/2460243/0/en/Caribou-Biosciences-Reports-Positive-Additional-Data-from-CB-010-Allogeneic-CAR-T-Cell-Therapy-Phase-1-ANTLER-Trial-at-the-European-Hematology-Association-EHA-2022-Hybrid-Congress.html

Jun 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next